Mathijs Scholtes MD

MD currently focusing on muscle-invasive bladder cancer within the Erasmus Urothelial Cancer Research Group (EURCG). I use descriptive genomics to identify biomarkers predictive of neoadjuvant chemotherapy response in patients and work on patient-derived tumoroids as a novel ex vivo model system to study bladder cancer

You can read about my project(s) here:

Tumor models